Search

Your search keyword '"FORREST, IAN"' showing total 343 results

Search Constraints

Start Over You searched for: Author "FORREST, IAN" Remove constraint Author: "FORREST, IAN"
343 results on '"FORREST, IAN"'

Search Results

2. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

5. Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK

7. Real-world data from 24 UK centres for the use of nintedanib for progressive fibrosing interstitial lung disease

12. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

19. sj-pdf-2-pmj-10.1177_02692163221101753 – Supplemental material for When should palliative care be introduced for people with progressive fibrotic interstitial lung disease? A meta-ethnography of the experiences of people with end-stage interstitial lung disease and their family carers

20. sj-pdf-1-pmj-10.1177_02692163221101753 – Supplemental material for When should palliative care be introduced for people with progressive fibrotic interstitial lung disease? A meta-ethnography of the experiences of people with end-stage interstitial lung disease and their family carers

31. sj-pdf-2-pmj-10.1177_02692163211059340 ��� Supplemental material for Which factors influence the quality of end-of-life care in interstitial lung disease? A systematic review with narrative synthesis

32. sj-pdf-3-pmj-10.1177_02692163211059340 ��� Supplemental material for Which factors influence the quality of end-of-life care in interstitial lung disease? A systematic review with narrative synthesis

33. sj-pdf-1-pmj-10.1177_02692163211059340 ��� Supplemental material for Which factors influence the quality of end-of-life care in interstitial lung disease? A systematic review with narrative synthesis

35. What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures study

37. Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients

39. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

40. Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis

43. Which factors influence the quality of end-of-life care in interstitial lung disease? A systematic review with narrative synthesis.

49. Respiratory follow-up of patients with COVID-19 pneumonia

50. British Thoracic Society Training Standards for Thoracic Ultrasound (TUS)

Catalog

Books, media, physical & digital resources